Abiomed, Inc. (ABMD)

2 members of Congress have disclosed 13 trades in Abiomed, Inc. (ABMD) via STOCK Act filings. The most recent disclosure was a sale by Josh Gottheimer on 14 September 2022. The most active traders have been Josh Gottheimer (7) and Gilbert Cisneros (6). Aggregate disclosed activity totals roughly $88.5K in purchases and $40K in sales (midpoint estimates from bracketed disclosure amounts).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Claim Free AssetCopy Automatically with eToro

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Past Performance is not an indication of future results.

Price data is not available for ABMD
This ticker may have been delisted, renamed, or is not publicly quoted, so no live price, statistics or chart can be shown. The congressional trades disclosed for it are listed below.

Congressional Trading Activity for ABMD

5 transactions
Compliance: 69%
Josh Gottheimer14 Sept 202216 Oct 2022SaleStock$1,001 - $15,000N/A
Gilbert Cisneros31 Dec 202011 Jan 2021PurchaseStock$1,001 - $15,000N/A
Gilbert Cisneros23 Dec 202011 Jan 2021PurchaseStock$1,001 - $15,000N/A
Gilbert Cisneros11 Aug 202014 Sept 2020PurchaseStock$1,001 - $15,000N/A
Gilbert Cisneros10 Jun 202017 Jul 2020SaleStock$1,001 - $15,000N/A

See every trade

Sign in free to see the full trade history for this stock.

Stock Overview

Market Data

Market Cap

$17.18B

Volume

15.7M

Beta

0.00

P/E Ratio

65.36

Fundamentals

EPS

$5.83

Div. Yield

-

Open

$380.78

Day Range

$380.55 – $381.28

Company Information

Sector
Healthcare
Industry
Medical - Devices
Exchange
NASDAQ · USD
Country
US
CEO
Michael Minogue
IPO Date
1987-07-29
Website
www.heartrecovery.com

Abiomed, Inc. specializes in the creation and distribution of advanced medical technology designed to support or substitute the heart's pumping action in patients suffering from heart failure, while also offering ongoing care for these individuals. I...

Earnings

Recent Quarters

Q3 20233 Nov
EPS-
Q2 20232 Aug
EPS-
Q1 202326 Apr
EPS-
Q4 20222 Feb
EPS-
Q3 20221 Nov
EPS$1.30
Beat 25.0%
Q2 20224 Aug
EPS$1.25
Beat 17.9%
Q1 202228 Apr
EPS$1.16
Beat 6.4%
Q4 20213 Feb
EPS$1.13
Beat 18.9%
Q3 202128 Oct
EPS$1.03
Beat 6.2%
Q2 20214 Aug
EPS$1.41
Beat 34.3%
Q1 202129 Apr
EPS$1.24
Beat 12.7%
Q4 202028 Jan
EPS$1.35
Beat 19.5%
Q3 202029 Oct
EPS$1.36
Beat 47.8%
Q2 20206 Aug
EPS$0.98
Beat 237.9%
Q1 202030 Apr
EPS$0.70
Miss 25.5%
Q4 20196 Feb
EPS$1.51
Beat 38.5%
Q3 201931 Oct
EPS$1.03
Beat 10.8%
Q2 20191 Aug
EPS$1.28
Beat 32.0%
Q1 20192 May
EPS$1.09
Beat 0.9%
Q4 201831 Jan
EPS$0.97
Beat 3.2%
Q3 20181 Nov
EPS$1.09
Beat 47.3%
Q2 201826 Jul
EPS$1.95
Beat 137.8%
Q1 20183 May
EPS$0.80
Beat 25.0%
Q4 20171 Feb
EPS$0.70
Beat 37.3%
Q3 201726 Oct
EPS$0.54
Beat 42.1%
Q2 201727 Jul
EPS$0.45
Beat 7.1%
Q1 20174 May
EPS$0.40
Beat 14.3%
Q4 201626 Jan
EPS$0.34
Beat 17.2%
Q3 201627 Oct
EPS$0.20
Miss 16.7%
Q2 201628 Jul
EPS$0.29
Beat 26.1%
Q1 20163 May
EPS$0.24
Beat 26.3%
Q4 20154 Feb
EPS$0.23
Beat 53.3%
Q3 201529 Oct
EPS$0.17
Beat 13.3%
Q2 20154 Aug
EPS$0.20
Beat 150.0%
Q1 20155 May
EPS$0.28
Beat 100.0%
Q4 201427 Jan
EPS$0.30
Beat 650.0%
Q3 201430 Oct
EPS$0.09
Beat 328.6%
Q2 201431 Jul
EPS$-0.04
Miss 335.3%
Q1 20141 May
EPS$0.09
Beat 12.5%
Q4 201330 Jan
EPS$0.11
Beat 120.0%
Q3 20136 Nov
EPS$0.07
Beat 2904.3%
Q2 20131 Aug
EPS$-0.04
Miss 166.7%
Q1 20132 May
EPS$0.09
Beat 28.6%
Q4 20126 Feb
EPS$0.07
Beat 0.0%
Q3 20121 Nov
EPS$0.13
Beat 160.0%
Q2 20122 Aug
EPS$0.08
Beat 166.7%
Q1 201216 May
EPS$0.06
Beat 0.0%
Q4 20113 Feb
EPS$0.05
Beat 766.5%
Q3 20113 Nov
EPS$0.02
Beat 122.2%
Q2 20114 Aug
EPS$-0.12
Miss 100.0%
Q1 201118 May
EPS$-0.05
Miss 14.3%
Q4 20103 Feb
EPS$-0.02
Beat 77.8%
Q3 20104 Nov
EPS$-0.09
Beat 35.7%
Q2 20104 Aug
EPS$-0.16
Miss 14.3%
Q1 201019 May
EPS$-0.13
Miss 8.3%
Q4 20094 Feb
EPS$-0.12
Beat 29.4%
Q3 20095 Nov
EPS$-0.21
Beat 0.0%
Q2 20096 Aug
EPS$-0.21
Miss 5.0%
Q1 200912 May
EPS$-0.23
Miss 43.8%
Q4 20085 Feb
EPS$-0.21
Miss 31.3%
Q3 200810 Nov
EPS$-0.18
Beat 18.2%
Q2 20087 Aug
EPS$-0.28
Miss 33.3%
Q1 200821 May
EPS$-0.27
Miss 42.1%
Q4 20077 Feb
EPS$-0.26
Miss 23.8%
Q3 20078 Nov
EPS$-0.29
Miss 38.1%
Q2 20079 Aug
EPS$-0.22
Miss 4.8%
Q1 200717 May
EPS$-0.22
Beat 8.3%
Q4 20065 Feb
EPS$-0.25
Beat 3.9%
Q3 20068 Nov
EPS$-0.33
Miss 50.0%
Q2 20068 Aug
EPS$-0.23
Miss 21.1%
Q1 20068 May
EPS$-0.14
Beat 0.0%
Q4 20052 Feb
EPS$-0.17
Miss 13.3%
Q3 20052 Nov
EPS$-0.11
Beat 31.3%
Q2 20054 Aug
EPS$-0.22
Miss 46.7%
Q1 200531 May
EPS$-0.01
Q4 200431 Jan
EPS$-0.01
Beat 8.4%
Q3 20041 Nov
EPS$0.02
Beat 166.7%
Q1 200430 Jun
EPS$-0.11
Q4 200331 Mar
EPS$-0.07
Q3 200331 Dec
EPS$-0.09
Q2 200330 Sept
EPS$-0.13
Q2 200311 Aug
EPS$-0.15
Beat 37.5%
Q1 20036 Jun
EPS$-0.15
Beat 31.8%
Q4 200213 Feb
EPS$-0.21
Beat 34.4%
Q3 200214 Nov
EPS$-0.25
Beat 32.4%
Q2 200215 Aug
EPS$-0.26
Beat 25.7%
Q1 200216 May
EPS$-0.32
Beat 3.0%
Q4 200124 Jan
EPS$-0.31
Beat 3.1%
Q3 200125 Oct
EPS$-0.34
Miss 9.7%
Q2 200126 Jul
EPS$-0.30
Miss 30.4%
Q1 200117 May
EPS$-0.20
Beat 0.0%
Q4 200025 Jan
EPS$-0.18
Miss 5.9%
Q3 200026 Oct
EPS$-0.07
Beat 41.7%
Q2 200027 Jul
EPS$-0.09
Beat 0.0%
Q1 200011 May
EPS$-0.17
Beat 5.6%
Q3 199931 Dec
EPS$-0.21
Q2 199930 Sept
EPS$-0.35
Q1 199930 Jun
EPS$-0.09
Q1 199912 May
EPS$-0.08
Beat 33.3%
Q4 199821 Jan
EPS$-0.13
Miss 18.2%
Q3 199821 Oct
EPS$-0.14
Miss 16.7%
Q2 199828 Jul
EPS$-0.03
Beat 70.0%
Q1 199828 May
EPS$-0.09
Miss 12.5%
Q4 199728 Jan
EPS$-0.07
Miss 40.0%
Q2 199730 Sept
EPS$0.06
Q1 199730 Jun
EPS$0.11
Q4 199631 Mar
EPS$0.06
Q3 199631 Dec
EPS$-0.05
Q2 199630 Sept
EPS$0.04
Q1 199630 Jun
EPS$0.05
Q4 199531 Mar
EPS$0.02
Q3 199531 Dec
EPS$0.03
Q2 199530 Sept
EPS$0.01
Q1 199530 Jun
EPS$0.01
Q1 199516 May
EPS$-0.01
Miss 100.0%
Q4 199424 Jan
EPS-
Q3 199426 Oct
EPS$-0.01
Miss 66.7%
Q1 199430 Jun
EPS$-0.02
Q4 199331 Mar
EPS$-0.05
Q3 199331 Dec
EPS$-0.03
Q2 199330 Sept
EPS$-0.03
Q1 199330 Jun
EPS$-0.06
Q4 199231 Mar
EPS$-0.06
Q3 199231 Dec
EPS$-0.07
Q2 199230 Sept
EPS$-0.10
Q1 199230 Jun
EPS$-0.09
Q4 199131 Mar
EPS$-0.12
Q3 199131 Dec
EPS$-0.10
Q2 199130 Sept
EPS$-0.10
Q1 199130 Jun
EPS$-0.08

3 politicians traded within 30 days

No dividend data available for this stock.

Stock Splits

Split History

2 Oct 2000Stock Split
Ratio2:1

Similar Stocks

Based on congressional trading patterns

Smart Recommendations
No similar stocks found
No congressional trading patterns available for recommendations

Frequently Asked Questions about ABMD

Which members of Congress have traded ABMD?
2 members of Congress have disclosed 13 trades in Abiomed, Inc. (ABMD) under the STOCK Act. The most active traders are Josh Gottheimer and Gilbert Cisneros.
When was ABMD most recently disclosed by Congress?
The most recent ABMD disclosure was a sale by Josh Gottheimer on 14 September 2022.
What is the total disclosed congressional trading volume for ABMD?
Members of Congress have disclosed approximately $88.5K in ABMD purchases and $40K in sales. These figures are midpoint estimates derived from the bracketed amount ranges used in STOCK Act filings.
How can I track new congressional trades in ABMD?
This ABMD page updates as soon as new STOCK Act disclosures are filed for Abiomed, Inc.. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
PoliticiansBillsArticlesPortfoliosPricingAboutLegalTerms of ServicePrivacy Policy
Français
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.